Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 136

1.

Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study.

Rouamba T, Valea I, Bognini JD, Kpoda H, Mens PF, Gomes MF, Tinto H, Kirakoya-Samadoulougou F.

Drugs Real World Outcomes. 2018 Sep;5(3):193-206. doi: 10.1007/s40801-018-0141-1.

2.

Patient Understanding of the Neuropsychiatric Risks Associated with Branded Bupropion Hydrochloride Products Used for Smoking Cessation.

Ascher J, Stemhagen A, Stender M, Win B, Winter C.

Drugs Real World Outcomes. 2018 Sep;5(3):181-191. doi: 10.1007/s40801-018-0140-2.

3.

Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs.

Sruamsiri R, Kameda H, Mahlich J.

Drugs Real World Outcomes. 2018 Sep;5(3):169-179. doi: 10.1007/s40801-018-0139-8.

4.

Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting.

Cartwright TH, Parisi M, Espirito JL, Wilson TW, Pelletier C, Patel M, Babiker HM.

Drugs Real World Outcomes. 2018 Sep;5(3):149-159. doi: 10.1007/s40801-018-0137-x.

5.

Real-World Adverse Effects of Capecitabine Toxicity in an Elderly Population.

van Beek MWH, Roukens M, Jacobs WCH, Timmer-Bonte JNH, Kramers C.

Drugs Real World Outcomes. 2018 Jun 22. doi: 10.1007/s40801-018-0138-9. [Epub ahead of print]

6.
7.

Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012-2016.

Uusküla A, Pisarev H, Kurvits K, Laius O, Laanpere M, Uusküla M.

Drugs Real World Outcomes. 2018 Jun;5(2):129-136. doi: 10.1007/s40801-018-0135-z.

8.

Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study.

Kuiper JG, van Herk-Sukel MPP, Castellsague J, Pottegård A, Berglind IA, Dedman D, Gutierrez L, Calingaert B, Hallas J, Sundström A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S.

Drugs Real World Outcomes. 2018 May 7. doi: 10.1007/s40801-018-0133-1. [Epub ahead of print]

9.
10.

Pattern of Antimicrobial Resistance among Bacterial Isolates from Urogenital Clinical Specimens: A Descriptive Study from the Buea Health District, Cameroon.

Amin ET, Njumkeng C, Kika BT, Fualefac A, Njukeng P.

Drugs Real World Outcomes. 2018 Jun;5(2):101-108. doi: 10.1007/s40801-018-0132-2.

11.

An Evaluation of "Drug Ineffective" Postmarketing Reports in Drug Safety Surveillance.

Misu T, Kortepeter CM, Muñoz MA, Wu E, Dal Pan GJ.

Drugs Real World Outcomes. 2018 Jun;5(2):91-99. doi: 10.1007/s40801-018-0131-3.

12.

Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics.

Lafeuille MH, Tandon N, Tiggelaar S, Kamstra R, Lefebvre P, Kim E, Yue Y, Joshi K.

Drugs Real World Outcomes. 2018 Mar;5(1):81-90. doi: 10.1007/s40801-018-0130-4.

13.

Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

Fairman KA, Davis LE, Peckham AM, Sclar DA.

Drugs Real World Outcomes. 2018 Mar;5(1):69-79. doi: 10.1007/s40801-017-0129-2.

14.

Quantitative Testing of Prescriber Knowledge Regarding the Risks and Safe Use of Albiglutide.

Koro C, Pientka J, Bainbridge V, O'Donnell N, Stender M, Stemhagen A.

Drugs Real World Outcomes. 2018 Mar;5(1):55-67. doi: 10.1007/s40801-017-0128-3.

15.

Contact Dermatitis after Prescription of an Ophthalmic Ointment Containing Fradiomycin Sulfate: A Retrospective Database Study Using Japanese Health Insurance Claims Data.

Sugimoto N, Kuribayashi K, Yamamoto Y, Nagayasu S, Suga O, Fujimoto Y.

Drugs Real World Outcomes. 2018 Mar;5(1):45-54. doi: 10.1007/s40801-017-0127-4.

16.

Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study.

Mahlich J, Tsukazawa S, Wiegand F.

Drugs Real World Outcomes. 2018 Mar;5(1):35-43. doi: 10.1007/s40801-017-0126-5.

17.

Adverse Drug Events and Medication Errors in African Hospitals: A Systematic Review.

Mekonnen AB, Alhawassi TM, McLachlan AJ, Brien JE.

Drugs Real World Outcomes. 2018 Mar;5(1):1-24. doi: 10.1007/s40801-017-0125-6. Review.

18.

Replication of Mini-Sentinel Study Assessing Mirabegron and Cardiovascular Risk in Non-Mini-Sentinel Databases.

Simeone JC, Nordstrom BL, Appenteng K, Huse S, D'Silva M.

Drugs Real World Outcomes. 2018 Mar;5(1):25-34. doi: 10.1007/s40801-017-0124-7.

19.

Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults.

Ie K, Chou E, Boyce RD, Albert SM.

Drugs Real World Outcomes. 2017 Dec;4(4):257-264. doi: 10.1007/s40801-017-0123-8.

20.

Prevalence and Variability in Medications Contributing to Polypharmacy in Long-Term Care Facilities.

Jokanovic N, Jamsen KM, Tan ECK, Dooley MJ, Kirkpatrick CM, Bell JS.

Drugs Real World Outcomes. 2017 Dec;4(4):235-245. doi: 10.1007/s40801-017-0121-x.

Supplemental Content

Loading ...
Support Center